The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Share Price has recovered about 10p or just over 11%. But it is only the beginnings of any real recovery to the 126p of three months ago, the 130p of six months ago or the 160p of a year ago. I do agree that the company is in the right markets, was right to cut the dividend, which remains excellent, and has shown positive recent figures. Perhaps there is hope still...
This is the only share in my ISA that I feel indignant about. I have held it for nearly four years and watched it slide continuously. Why the indignation? It is the continuous stream of buy recommendations from analysts. I can find none that say even overweight let alone hold. I continue to hold only because I am quite deeply in (by my reckoning) and because if I add in the great dividends I have received I am not so badly hit. The dividend is about 9% at current prices, which is great. Why, oh why, do analysts continue to rate these a strong buy?
8p is better than any savings plan can offer so not to be scoffed at and for years now too much paid out in divs to the board and shareholders in my opinion. The company has to lower divs other wise they'd run out of money! So the company is going in the right direction...
To be recommended to shareholders at 8p.
My 10204 was a buy and two others done just after mine are also buys! Great company and this is the lowest these have been, expect this to rise from here. Comerciante, the court actions will be expensive to defend.. True but Hansard will claim these costs back and yes buying at the current price must be a sure fire winner. GLA
no ex d now
http://www.britishbulls.com/StockPage.asp?CompanyTicker=HSD&MarketTicker=Financials&TYP=S
It is unrealistic and even irresponsible one might say for a company to pay 12% dividend when the business is in need of investment (nice though it is for us shareholders). Broker recs are positive, trends are positive, we are in the right markets to grow ie., Far East & Latin America - this bodes well. Investors responded favourably on the results seeing the price drop as a buying opportunity - I am very very comfortable in this share. The opinion of the board that there is no legal case to answer sounds just about correct to me nonetheless the court actions will be expensive to defend - they have this included in forward planning so the SP should not remain depressed for any extended period Buying at the current price must be a sure fire winner IMO, Best wishes to all
This might get more support with a sustainable dividend. I thought the key positiive point to take from the rsults was that significant investment is ongoing to generate the regular premium business in various parts of the world. Over the next few years, the required investment should fall and the profits, at high margin, should start to roll in. On the negative side, some of that increase may be counteracted by falls in single premium business and possible litigation payments. I suspect the share price will remain depressed to some extent whilst the legal actions are in the background, and it seems there will be no resolution for at least a year. So long as it can keep paying out at 8p or better, it remains in the top end of yielders and the high margins and increasing cash inflow should keep it comfortably profitable.
Oh the sleeepless nights of the small investor... Having slept on last weeks performance I agree with comerciante about the new dividend strategy. Cable & Wireless comms did the same a few months back and have steadily progressed since. Hansard still pays a good dividend and the company is more soundly based for having taken the prudent route. The board have shown willing to actually take action. At this price it is a buy.
Excellent strategy by the BOD - this share can now grow back to where it was a year ago. Looking for steady growth over the next 12 months. ATB
"New business levels in the first two months of the financial year reflect the cautious stance of policyholders and are significantly below the level of the corresponding period in the prior year. However the board expects new business to gather momentum in the second quarter on the back of new product launches and also more positive investment market conditions." IFRS profit after tax fell to £11.2m during the year from £16.5m. Chief Executive Leonard Polonsky said: "In line with our new business strategy we continued to invest in regular premium flows and to focus on growth markets." He cautioned: "Single premium business remains constrained by market volatility and the instability in the Eurozone that shows few signs of abating. While the economic environment remains challenging, we have a robust strategy in place and are successfully developing the business in the growth markets of the Far East and Latin America." Hansard has recommended a final dividend payment of 8p, unchanged from last year.
Long-term savings provider Hansard said continued instability in the Eurozone weighed on new business sales and, it warned, damaging market forces show few signs of abating. As at 30 June assets under administration fell to £1m for the year ended June 30th 2012 from £1.2m before. In 2011 investment income came in as a £112.9m profit but, for the year ended June 30th 2012, it recorded a £145.7m loss. Single premium new business sales more than halved to £51.3m compared to £109.1m the year before. Regular premium new business sales increased to £124.4m during the period from £112m earlier.
now moved upto res at 120, will review as and when atvb
Buying up !!!
Not many sellers - looks like this is a buying opportunity
All pretty well expected, give it a day or three and the SP will be rising again. This is a knee jerk reaction - all today's news has already been factored into the share price IMO, All the best.
The Board has proposed a final dividend of 8.0p per share which, if approved by the shareholders, represents a total dividend of 13.9p per share in respect of the financial year (2011: 13.75p), an increase of 1.1%. The proposed final dividend is at the same level as the previous year. Over the last two years the Company has paid dividends that have been £16m in excess of cash generated by the business. The Board believes that now is an appropriate time to adjust the dividend to a level commensurate with the surplus cash generated by the business. Dividend payments for the year ended 30 June 2013 therefore are expected to total 8.0p per share and it is the Board's intention to pursue a progressive policy thereafter. Just my luck having purchased another batch...
bought 96.5 s/order at 113.5 short term atvb
A Norwegian Judge says Hansard has a case to answer. Investors have complained that of some investments for some policies were wrongly chosen. Hansard is arguing, correctly in my view, that they do not offer financial advice and are appealing this preliminary judgement. Source is the latest financial report for June 2012 page 4.
This seems to be the worst possible result from cases brought by dissatisfied investors with Hansard. The company is fighting all cases.
I wavered over the buy recommendation again but have just added another tranche to my ISA. I had not read about the court case till TheChrist pointed to it. I'm not sure how much affect it has had. My average cost is now £1.52 per share so I must be on some sort of dividend high to keep adding. How can a board with SmilingAssassin and TheChrist be dead... What am I saying? 'SmilingAssassin' and 'TheChrist' something must be dead.
Difficult to ignore the yield on this one so I bought some more. There is a slight cloud hanging over this from a court case as reported in various RNS, which is probably partly responsible for the low price, but it still looks way oversold. HSD, CSN and CIFU have all been in the 10-15% dividend category the last few months and each looks relatively safe. Results here later in the month....
been share tipped into this co, 12% divi is quite generous !! mind u the board is as dead as a doornail !!
I have lost on these shares having held them for five years, but I love the yearly dividends. The dividend is almost 12% at current price. Adding in the dividends I suppose I am very slightly up but only just. I bought them when I believed analysts who expected prices to go up 50%, but of course they never have. After all that the company is definitely sound and I am certainly not going to sell now as I think they are on the way back. i think they are a buy because of the prospects and the dividend.